Taste masking of Etoricoxib by using ion-exchange resin

Pharmaceutical Development and Technology

Volumn 15, Issue 5, 2010, Pages 511-517

  Patra, Sradhanjali ^a   Samantaray, Rakesh ^a   Pattnaik, Saswat ^a   Barik, B B ^a  

^a UTKAL UNIVERSITY   (India)

Author keywords

Drug resin complex; Drug loading efficiency; Etoricoxib; Indion 204 resin; Taste masking

Indexed keywords

ETORICOXIB; ION EXCHANGE RESIN; WATER;

ARTICLE; BATCH PROCESS; BITTER TASTE; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG RELEASE; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; PH; PRIORITY JOURNAL; SALIVA; TABLET PROPERTY; X RAY DIFFRACTION;

ADMINISTRATION, ORAL; CATION EXCHANGE RESINS; CHEMISTRY, PHARMACEUTICAL; CYCLOOXYGENASE 2 INHIBITORS; DRUG CARRIERS; DRUG COMPOUNDING; HUMANS; PYRIDINES; SULFONES; TASTE;

EID: 77956152778     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450903322787     Document Type: Article

References (18)

1. Leclercq MG. Malaise. Etoricoxib (Arcoxia). Rev Med Liege 2004;59:345-349.
2. Menjoge AR, Kulkarni GM. Coating compositions for bitterness inhibition. 2007. United States Patent No. US 7,294,347.
3. Patel DM, Patel MM. Optimization of fast dissolving Etoricoxib tablets prepared by sublimation technique. Indian J Pharmaceut Sci 2008;70(1):71-76.
4. Chaudhari PD, Kolhe SR, Chaudhari SP, More DM. Use of cation exchange resins to optimize the taste masking of bitter drug Rizatriptan Benzoate. Indian Drugs 2006;43(10):795-799.
5. Kleinert HD, Baker WR, Stein HH. Ion exchange resin complexes: An approach to mask the taste of bitter drugs. Pharm Tech 1993;17:30.
6. Sugao H, Yamazaki S, Shiozawa H. Taste masking of bitter drug powder without loss of bioavailability by heat treatment of wax-coated microparticles. J Pharmaceut Sci 1998;87:96-100.
7. Kasture AV, Wadodkar SG, Mahadik KK, More HN. A textbook of pharmaceutical analysis and instrumental methods. Published by Nirali Publication. Address of the publisher is Abhyudaya Pragati, 1312, Shivaji Nagar,Of. J.M. Road, Pune 411005, Maharashtra, India. 8th ed. 2002.
8. Bhalekar M, Avari JG, Jaiswal SB. Cation-exchanger in pharmaceutical formulation. Indian J Pharm Sci 2004;38:184-187.
9. Prabhu Namita B, Rao L, Amin Purnima D. Studies on taste masking of drotaverine hydrochloride and its formulation. Indian Drugs 2007;44(11):848-851.
10. Hughes L. Ion exchange resin unique solution to formulation problem. Pharmaceutical technology excipients and solid dosage form. 2004. Accessed from the website: www.pharmtech. com.
11. Chaubal MV. Synthetic polymer-based ion exchange resin. Drug Deliv Technol 2006:6-8.
12. Borodkin S, Sundberg DP. Chewable tablets including coated particles of pseudo-ephedrine weak cation exchange resin. 1971. United States Patent No. US 3,594,470.
13. Long G. Biochemists handbook. Princeton, NJ: D. Van Nostrand; 1961:909.
14. Avari JG, Bhalekar M. Cation exchange resins for taste masking and rapid dissolution of sparfoxacin. Indian Drugs 2004;41:19-23.
15. Pisal S, Zainnuddin R, Nalawade P, Mahadik K, Kadam S. Molecular properties of ciprofoxacin-indion 234 complexes. AAPSPharmSciTech 2004;62:1-8.
16. World Health Organization (WHO). Quality control methods for medicinal plants. Geneva: WHO 1998:38-40.
17. Borodkin S, Yunker MH. Interaction of amine drugs with a polycar-boxylic acid ion-exchange resin. J Pharm Sci 1970;59:481-486.
18. Hughes L. New uses of ion exchange resin in pharmaceutical formulation. Rohm & Haas Research Laboratories. Pharm Technol Excipients and solid dosage forms. 2004. Accessed from the website: http://www.pharmtech.com/